Global Oligonucleotide Synthesis Market Size, Share & Trends Analysis 2014-2025 by End Use, Product (Column-based, Array-based, Services) & Application (PCR Primer, FISH) - ResearchAndMarkets.com
The "Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report By End Use, By Product (Column-based, Array-based, Services), By Application (PCR Primer, FISH), And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
The global oligonucleotide synthesis market size is expected to reach USD 3.9 billion by 2025 at a 12.4% CAGR during the forecast period. Continuous rise in usage of oligonucleotide synthesis across various aspects of human health management, from molecular diagnostics to therapeutics, is spurring revenue growth.
The recent success of oligonucleotide-based drugs in medicine due to increase in number of FDA-approved products is anticipated to boost revenue generation in this market. As of September 2017, there are six approved oligonucleotide therapeutic products.
A substantial number of oligos are being investigated for their usage in targeting various infectious diseases. For instance, dsDNA thioaptamers are reported to target the ribonuclease H (RNase H) domain of HIV-RT and are demonstrated to inhibit HIV-RT when used in vitro.
In addition, demand for cancer-related thioapatmers that can detect presence as well as target tumor growth factors, such as TGF-, is on a continuous rise. This, in turn, has led to increase in investments for exploring the significance of custom oligonucleotide synthesis in cancer research.
Key Topics Covered:
Chapter 1 Executive Summary
1.1 Market Snapshot
Chapter 2 Research Methodology
2.1 Information procurement
2.2 Information or Data Analysis
2.3 Market Formulation - Validation
2.4 Approaches for Market Estimation
Chapter 3 Oligonucleotide Synthesis Market Variables, Trends - Scope
3.1 Market Segmentation - Scope
3.1.1 Market driver analysis
126.96.36.199 Strong pipeline of oligonucleotide therapeutics in clinical trials
188.8.131.52 Changing regulatory environments for genetic research and its applications in healthcare
184.108.40.206 High R - D spending of pharmaceutical - biotechnology companies
220.127.116.11 Increased public - private spending on genomics
18.104.22.168 Technological advancements in gene editing technologies
22.214.171.124 Exponentially declining cost of sequencing
126.96.36.199 Rising demand for synthetic genes
3.1.2 Market restraint analysis
188.8.131.52 Need for advanced oligo synthesis solutions
184.108.40.206 High cost associated with genomics research
220.127.116.11 Increasing wages of skilled employees in life science sector
18.104.22.168 Lack of skilled professionals and research support in undeveloped countries
3.2 Penetration - Growth Prospect Mapping for Application, 2017
3.3 Oligonucleotide Synthesis -SWOT Analysis, By Factor (Political - Legal, Economic And Technological)
3.4 Industry Analysis - Porter's
Chapter 4 Oligonucleotide Synthesis Market Categorization: Product Estimates - Trend Analysis
4.1 Global Oligonucleotide Synthesis Market: Product Movement Analysis, 2017 - 2025
4.2.1 Global oligonucleotides market, 2014 - 2025 (USD Million)
4.2.2 Oligonucleotides, by product type
22.214.171.124 Column-based oligos
126.96.36.199 Array-based oligos
4.2.3 Oligonucleotides, by nucleic acid type
188.8.131.52 DNA oligos
184.108.40.206 RNA oligos
4.3 Equipment/ Synthesizers
4.5.1 Global oligonucleotide services market, 2014 - 2025 (USD Million)
4.5.2 Oligo synthesis
220.127.116.11 25 nmol
18.104.22.168 50 nmol
22.214.171.124 200 nmol
126.96.36.199 1,000 nmol
188.8.131.52 10,000 nmol
Chapter 5 Oligonucleotide Synthesis Market Categorization: Application Estimates - Trend Analysis
5.1 Global Oligonucleotide Synthesis Market: Application Movement Analysis, 2017 - 2025
5.2 PCR primers
5.3 PCR Assays - Panels
5.5 DNA Microarrays
5.6 Fluorescence In Situ Hybridization (FISH)
5.7 Antisense Oligonucleotides
5.8 Other Applications
Chapter 6 Oligonucleotide Synthesis Market Categorization: End Use Estimates - Trend Analysis
6.1 Global Oligonucleotide Synthesis Market: End Use Movement Analysis, 2017 - 2025
6.2 Pharmaceutical - Biotechnology Companies
6.3 Diagnostic Laboratories
6.4 Academic Research Institutes
Chapter 7 Oligonucleotide Synthesis Market Categorization: Regional Estimates - Trend Analysis, by Product, Applications, - End Use
7.1 Oligonucleotide Synthesis Market Share By Region, 2017 - 2025
Chapter 8 Competitive Landscape
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- GE Healthcare Dharmacon Inc.
- Agilent Technologies
- Kaneka Eurogentec S.A.
- Integrated DNA Technologies, Inc.
- LGC Biosearch Technologies
- Biolegio B.V.
For more information about this report visit https://www.researchandmarkets.com/research/g2shjn/global?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181119005363/en/